A (127) | B (8) | C (26) | D (12) | E (21) | F (6) | G (1) | H (10) | I (19) | L (8) | M (7) | N (3) | O (8) | P (15) | R (29) | S (35) | T (1) | U (5) | V (14)
Title Author Last update
Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA) (OCEAN) admin
Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA) (OCEAN) admin
Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA) (OCEAN) roman
Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA) (OCEAN) roman
Efficacy and Safety of Fluticasone Furoate/ Umeclidinium/ Vilanterol (FF/ UMEC/ VI) in Chinese Participants With Inadequately Controlled Asthma admin
Efficacy and Safety Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Participants Aged Greater Than or Equal to (>) 18 Years With Severe Eosinophilic Asthma (PRISM) admin
EGPA admin
EGPA roman
EGPA roman
EGPA admin
EGPA roman
EGPA roman
EGPA roman
EGPA roman
EGPA roman
ENDURA-1: Depemokimab as an Extended treatmeNt Duration Biologic in Adults with Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation roman
ENDURA-1: Depemokimab as an Extended treatmeNt Duration Biologic in Adults with Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation roman
ENDURA-1: Depemokimab as an Extended treatmeNt Duration Biologic in Adults with Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation roman
ENDURA-2: Depemokimab as an Extended treatmeNt Duration Biologic in Adults with Chronic Obstructive Pulmonary Disease (COPD) and type 2 inflammation roman
ENDURA-2: Depemokimab as an Extended treatmeNt Duration Biologic in Adults with Chronic Obstructive Pulmonary Disease (COPD) and Type 2 inflammation roman
ENDURA-2: Depemokimab as an Extended treatmeNt Duration Biologic in Adults with Chronic Obstructive Pulmonary Disease (COPD) and Type 2 inflammation roman